ANPASSBARE INJEKTIONSVORRICHTUNG
European patent · EP3294373 · In force
Register entry
- Publication number
- EP3294373
- Application number
- EP16721060
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- May 3, 2016
- Published
- Mar 21, 2018
- Granted
- Apr 1, 2020
- Protection ends at the latest
- May 2, 2036
- Next annual fee due
- May 31, 2027
- IPC classes
- A61M 5/00 (2006.01)A61M 5/20 (2006.01)A61M 5/31 (2006.01)A61M 5/32 (2006.01)
- Priority
- CH 6672015 13.05.2015
- PCT application
- PCT/CH2016/000074 03.05.2016
- PCT publication
- WO2016/179713 17.11.2016
- Filing language
- German
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jun 1, 2026
Change
Published in Swissreg on 01.06.2026
- Jun 1, 2025
Change
Published in Swissreg on 01.06.2025
- Jun 2, 2024
Change
Published in Swissreg on 02.06.2024
- Jun 2, 2023
Change
Published in Swissreg on 02.06.2023
- Oct 27, 2020
Transferred
- Owner
- Tecpharma Licensing AG, Brunnmattstrasse 6, 3401 Burgdorf → Ypsomed AG, Brunnmattstrasse 6, 3401 Burgdorf
Published in Swissreg on 27.10.2020
- Apr 1, 2020
Granted
Published in Swissreg on 01.04.2020
Parties
Inventor
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.